z-logo
open-access-imgOpen Access
Inhibition of phosphatidylinositol 3-kinase activity by association with 14-3-3 proteins in T cells.
Author(s) -
Nathalie Bonnefoy,
YunCai Liu,
Maria von Willebrand,
Amy Sung,
Chris Elly,
Tomas Mustelin,
Hiroyuki Yoshida,
Kimishige Ishizaka,
Am Altman
Publication year - 1995
Publication title -
proceedings of the national academy of sciences of the united states of america
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.92.22.10142
Subject(s) - phosphatidylinositol , signal transduction , fusion protein , biology , immunoprecipitation , protein subunit , kinase , microbiology and biotechnology , phosphorylation , wortmannin , enzyme , receptor , recombinant dna , tyrosine phosphorylation , biochemistry , gene
Proteins of the 14-3-3 family can associate with, and/or modulate the activity of, several protooncogene and oncogene products and, thus, are implicated in regulation of signaling pathways. We report that 14-3-3 is associated with another important transducing enzyme, phosphatidylinositol 3-kinase (PI3-K). A recombinant 14-3-3 fusion protein bound several tyrosine-phosphorylated proteins from antigen receptor-stimulated T lymphocytes. PI3-K was identified by immunoblotting and enzymatic assays as one of the 14-3-3-binding proteins in resting or activated cells. Moreover, endogenous 14-3-3 and PI3-K were coimmunoprecipitated from intact T cells. Far-Western blots of gel-purified, immunoprecipitated PI3-K with a recombinant 14-3-3 fusion protein revealed direct binding of 14-3-3 to the catalytic subunit (p110) of PI3-K. Finally, anti-phosphotyrosine immunoprecipitates from activated, 14-3-3-overexpressing cells contained lower PI3-K enzymatic activity than similar immunoprecipitates from control cells. These findings suggest that association of 14-3-3 with PI3-K in hematopoietic (and possibly other) cells regulates the enzymatic activity of PI3-K during receptor-initiated signal transduction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here